Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
2023 · Nature Medicine · 227 citations
https://doi.org/10.1038/s41591-022-02182-7
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
16
Papers
600
Citations
11
h-index
12
i10-index
Erin E. Karski is an academic researcher from Allogene Therapeutics (United States). The author has contributed to research in topics: CAR-T cell therapy research & Neuroblastoma Research and Treatments & Cancer, Hypoxia, and Metabolism. The author has an h-index of 11, co-authored 14 publications.
https://doi.org/10.1038/s41591-022-02182-7
https://doi.org/10.1182/blood-2020-140641
Click to start Chat